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Synthesis of 10b-fluorinated analogues of 
protubonine A and its 11a-epimer via 
fluorocyclisation of tryptophan-containing 
dipeptides 
Tomoya Fujiwara,* Hiroko Yasuda, Yushi Nishimura, Hisanori Nambu and 
Takayuki Yakura* 
Synthesis of 10b-fluorinated analogues of protubonine A and its 11a-epimer was accomplished 
using fluorocyclisation of tryptophan-containing dipeptides with N-fluoro-2,4,6-trimethylpyridinium 
triflate to 3a-fluoropyrrolo[2,3-b]indoles as a key step. Acetylation of the indole nitrogen and the 
following diketopiperazine formation gave the 10b-fluorinated analogues of protubonine A and its 
11a-epimer. 
 
Introduction 
Organofluorine compounds have fascinated medicinal chemists 
ever since 9α-fluorocortisol was reported to have much higher 
biological activity than cortisol.1 An extensive number of 
fluorine-containing pharmaceuticals have been developed to 
date,2 some of which have become blockbusters.3 The growing 
interest in organofluorine compounds in medicinal chemistry 
stemmed from the unique properties of fluorine atom(s). 
Fluorine has the highest electronegativity and the smallest Van 
der Waals radius next to hydrogen.2a,4 The C–F bond is far 
stronger than C–H, C–O and C–X (X = Cl, Br and I) bonds.2a,4 
Therefore, incorporation of fluorine atom(s) into bioactive 
molecules often produces dramatic changes in their chemical, 
physical and pharmacological properties.2a,5 For example, when 
a hydrogen in molecules is replaced with a fluorine, the 
fluorinated molecules often have different reactivity from the 
parent fluorine-free ones, although the replacement has little 
effect on recognition of the molecules by proteins.2a,5 
Replacement of a hydroxy group with a fluorine can also be 
utilised for producing isosteric analogues.2a,5 Introduction of 
multiple fluorine atoms often increases lipophilicity.2a,5 
Protubonine A is a pyrroloindole alkaloid with a 
diketopiperazine (DKP) structure, which was isolated by Ahn 
and Oh in 2011 from an ethyl acetate extract of the marine-
derived fungus Aspergillus sp. SF-5044 (Fig. 1).6 The absolute 
configuration of protubonine A was originally determined to be 
3S,5aR,10bR,11aR, as shown in Fig. 1 as 1.6 Interestingly, 1 has 
an unnatural (R)-configuration in the tryptophan moiety and 
would be derived biosynthetically from D-tryptophan and L-
leucine. Since D-amino acids reportedly play important roles in 
exhibiting various biological functions,7 we were interested in 
the potential biochemical importance of this rare pyrroloindole 
alkaloid having an (R)-configuration.8 
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Fig. 1 Structures of 11a-epi-protubonine A (1), protubonine A (2) and their 
fluorinated analogues 3 and 4. 
As a part of our studies on the design, synthesis and 
biological evaluation of fluorine-containing bioactive 
compounds,9 we recently reported a versatile procedure for a 
fluorocyclisation reaction of tryptamines 5 with N-fluoro-2,4,6-
trimethylpyridinium triflate (7), obtaining the corresponding 
3a-fluoropyrrolo[2,3-b]indoles 6 (Scheme 1).10 Since the 
replacement of the 10b-hydroxy group of 1 with a fluorine 
ARTICLE Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
would generate a useful analogue for understanding the 
biochemical behaviour of 1, we envisaged application of our 
fluorocyclisation reaction to the synthesis of the 10b-
fluorinated analogue 3 of 1. However, unfortunately, after we 
started our synthesis of 3, de Lera and co-workers reported that 
in actuality, protubonine A is represented by 2 and has a 
3S,5aR,10bR,11aS configuration.11 In this paper, we report the 
synthesis of a 10b-fluorinated analogue of originally proposed 
protubonine A (3) and that of the revised one (4) via 
fluorocyclisation of tryptophan derivatives with 7 as a key step.  
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Scheme 1 Fluorocyclisation reaction of tryptamines 5 with N-fluoro-2,4,6-
trimethylpyridinium triflate (7). 
Results and discussion 
Our simple retrosynthetic analysis is illustrated in Scheme 2. 
Opening the DKP ring of 3 leads to dipeptide 8, which includes 
3a-fluoropyrrolo[2,3-b]indole 9 and N-carbobenzyloxy(Cbz)-L-
leucine (10). The fluoropyrroloindole 9 would be formed by our 
reported fluorocyclisation of N-Cbz-D-tryptophan methyl ester 
(11). Since 3 includes an unnatural D-amino acid, the DKP ring 
of 3 has a trans-relationship between the C-3 and C-11a 
positions, in contrast to the cis-relationship of the generally 
observed DKP ring in natural products. This suggests that 
construction of the trans-DKP ring of 3 is easier than that of 
natural cis-DKPs.12 In addition, 8 contains a proline structure in 
its dipeptide system. It is well-known that the DKP forming 
reaction of dipeptides containing proline as a C-terminal 
residue is generally much faster than that of other dipeptides.12 
On the basis of these two considerations, we planned to form 
the DKP ring at the final stage in our synthesis.13 Moreover, we 
were very interested in the stereoselectivity of the 
fluorocyclisation of 11 relative to the selenocyclisation and 
bromocyclisation of similar tryptophan derivatives with N-
(phenylseleno)phthalimide14 and N-bromosuccinimide,14d,15 
respectively. 
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Scheme 2 Retrosynthetic analysis of the 10b-fluorinated analogue 3 of 11a-epi-
protubonine A. 
Our synthesis commenced from D-tryptophan (12) shown in 
Scheme 3. Protected tryptophan 11 was prepared in excellent 
yield by esterification of 12 with thionyl chloride in anhydrous 
methanol, followed by protection of the primary amino group 
with benzyl chloroformate in the presence of sodium 
bicarbonate. Fluorocyclisation of 11 according to our reported 
procedure,10 which employed 1.5 equiv. of 7 in anhydrous THF 
at 60 °C for 8.5 h, yielded an inseparable mixture of 
diastereomeric fluoropyrroloindoles 13a and 13b in an 83% 
yield. Unfortunately, no diastereoselectivity (dr: ca. 1:1) was 
observed. Acetylation of the mixture of 13a and 13b with acetic 
anhydride (Ac2O) and pyridine was rather slow and required 2 
days at 60 °C to produce fully protected fluoropyrroloindoles 
14a and 14b in an 82% yield. Although separation of 14a and 
14b by silica gel column chromatography proved difficult, 
small amounts of pure 14a and 14b were isolated to estimate 
their stereochemistries by 1H NMR spectroscopic analysis (Fig. 
2). Taniguchi and Hino reported that the 1H chemical shifts of 
ester methyl protons of 16a and 16b were quite different.16 
Owing to the shielding effect of the indole ring, the ester 
methyl protons of 16a, having an anti relationship between the 
H-3a and CO2Me group, appeared at a higher field (dH 3.11 
ppm) compared with the ester methyl protons of 16b (dH 3.63 
and 3.72 ppm) that have a syn relationship. Thus, the 
stereochemistry of 14a and 14b was assigned by comparing the 
chemical shifts of the ester methyl protons of the two isomers. 
The product having the ester methyl protons appeared at a 
higher field (dH 3.09 ppm) is to be the anti-isomer 14a, 
whereas another product having them appeared at a lower field 
(dH 3.43 and 3.78 ppm) is to be the syn-isomer 14b. Removal 
of the Cbz groups of the mixture of 14a and 14b with hydrogen 
gas and a Pd/C catalyst gave 8-acetylfluoropyrroloindoles 15a 
and 15b in 45% and 43% yields, respectively. However, 
condensation of either 15a or 15b with 10, in the presence of 
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coupling agents such as O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorophosphate and O-(6-
chlorobenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
tetrafluoroborate, resulted in the recovery of the starting 
material. Hydrogenation of a mixture of 13a and 13b to remove 
their Cbz groups was unsuccessful, producing a complex 
mixture. 
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Scheme 3 Attempted synthesis of dipeptide 8. 
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Fig. 2 Estimation of stereochemistry of fluoropyrroloindoles 14a,b. a) Two 
methyl signals were observed because of the presence of the rotamers, b) ref. 16. 
We subsequently attempted fluorocyclisation of dipeptide 
18 as an alternative route to 3 (Scheme 4). Condensation of D-
tryptophan methyl ester (17) with 10 in the presence of 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC·HCl), 1-hydroxybenzotriazole (HOBt) and N-
methylmorpholine (NMM) produced 18 in an 83% yield. Since 
18 has a bulky leucine moiety at the nucleophilic nitrogen atom, 
we were concerned that the reactivity of 18 for 
fluorocyclisation might decrease. Fortunately, fluorocyclisation 
of 18 with 1.5 equiv. of 7 at 60 °C proceeded smoothly, 
generating a mixture of the corresponding fluoropyrroloindoles 
20a and 20b in an 84% yield. Again, no diastereoselectivity (dr: 
ca. 1:1) was observed. In contrast to the high stereoselectivity 
of the selenocyclisation14 and bromocyclisation14d,15 of 
tryptophan derivatives, the fluorocyclisation of 18 showed no 
stereoselection. This unfortunate result can be rationalized by 
the formation of indolenine intermediates such as 19.14a Owing 
to the difficulty of the separation of 20a and 20b, we attempted 
separation and determination of their stereochemistry after 
acetylation. Treatment of the mixture of 20a and 20b with 
Ac2O and pyridine at 60 °C for 42 h afforded an inseparable 
mixture of 8 and 21 (8:21 = ca. 2:1) in a 65% yield and a 
substantial amount (<22%) of unreacted 20b. This suggested a 
significant difference in the reactivity of 20a and 20b. When 
acetylation of the mixture of 20a and 20b was stopped after 3 h, 
ca. 17:1 mixture of 8 and 21 was obtained in a 45% yield, and 
20b was recovered in a 47% yield. Acetylation of pure 20b was 
accomplished by a longer reaction (50 h) to generate pure 21 in 
a 52% yield accompanied with a 41% recovery of the starting 
material 20b. The stereochemistry of 8 and 21 was determined 
by a comparison of the 1H NMR spectra of both isomers. Since 
the ester methyl protons of 8 appeared at a higher field (dH 3.21 
ppm) compared with those of 21 (dH 3.70 and 3.83 ppm), 8 was 
determined to be the anti-isomer and 21 the syn-isomer. When 
8 was treated with Pd/C under a hydrogen atmosphere, 
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deprotection and subsequent DKP formation occurred smoothly 
after 4 h as expected, yielding the desired 10b-fluorinated 
analogue 3 in a 50% yield. On the other hand, a similar reaction 
of 21 was faster, requiring only 2 h to generate the 5a,10b-
epimer of 3 (22) in a higher yield (78%). 
Finally, we applied the procedure to synthesise 4 (Scheme 
5). Fluorocyclisation of N-Cbz-L-Leu-L-Trp-OMe (23)17 with 7 
gave the corresponding fluoropyrroloindoles 24a and 24b 
(24a:24b = ca. 1:1) in a 77% yield. Acetylation of the mixture 
of 24a and 24b for 4 h generated ca. 30:1 mixture of 25a and 
25b in a 49% yield, and 24b was recovered in a 43% yield. 
Recrystallisation of the mixture of 25a and 25b from hexane 
and dichloromethane gave 25a in pure form. Recovered 24b 
was acetylated again for 50 h to give pure 25b (52%) 
accompanied with a 22% recovery of 24b. The stereochemistry 
of 25a and 25b was determined by the 1H NMR spectroscopic 
analysis. Catalytic hydrogenation of 25b fortunately produced 
the desired 10b-fluorinated analogue 4 in an 87% yield. A 
similar reaction of 25a required longer reaction time (5 h) to 
generate the 5a,10b-epimer 26 in an 86% yield.  
Conclusions 
We succeeded in synthesising the 10b-fluorinated analogue of 
originally proposed protubonine A (3) and that of the revised 
one (4) using our fluorocyclisation as a key step. Treatment of 
18 with 7 at 60 °C generated 20a and 20b in high yields, 
although no stereoselectivity was observed. Acetylation of 20a 
and 20b produced 8 and 21, respectively. The stereochemistry 
of 8 and 21 was easily determined by 1H NMR spectroscopic 
analysis. Deprotection and following trans-DKP formation of 8 
and 21 under hydrogenation conditions proceeded smoothly to 
produce 3 and its 5a,10b-epimer 22, respectively. Synthesis of 4 
and its 5a,10b-epimer 26 was accomplished by similar synthetic 
procedure. A difference in reactivity between the diastereomers 
was observed both during acetylation and the subsequent DKP 
formation. 
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Scheme 4 Synthesis of 10b-fluorinated analogue 3 and 5a,10b-epimer 22. 
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Melting points were determined using a Yanaco micro melting 
point apparatus and are uncorrected. Optical rotations were 
determined using a JASCO P-2100 polarimeter. Infrared (IR) 
spectra were recorded using a JEOL FT/IR-460Plus 
spectrometer. All NMR spectra were recorded using a JEOL 
ECX-400P or JEOL ECA-500II spectrometers. Proton (1H) 
NMR spectra were recorded at 400 or 500 MHz. Carbon-13 
(13C) NMR spectra were recorded using the broadband proton 
decoupling at 100 or 126 MHz. Fluorine-19 (19F) NMR spectra 
were recorded at 376 or 470 MHz. All chemical shifts, δ, are 
stated in units of parts per million (ppm), relative to a standard. 
For 1H NMR, the reference point is TMS (= 0.00 ppm). For 13C 
NMR, the reference point is CDCl3 (= 77.0 ppm). For 19F NMR, 
the reference point is CFCl3 (= 0.00 ppm). High and low 
resolution electron ionization (EI) mass spectra were recorded 
using a JEOL JMS-GCmate II spectrometer. Values are 
reported as a ratio of mass to charge (m/z). Column 
chromatography was performed on Nacalai Tesque Silica Gel 
60 PF254 (0.005–0.050 mm), Kanto chemical silica gel 60N 
(0.040–0.050 mm) or Merck 9385 silica gel 60 (0.040–0.063 
mm). Thin layer chromatography was performed on Merck 
5715 silica gel 60 F254 or Merck 5554 silica gel 60 F254. 
N-Benzyloxycarbonyl-D-tryptophan methyl ester (11). 
D-Tryptophan (1.22 g, 6.00 mmol) was dissolved in anhydrous 
MeOH (20 mL) and thionyl chloride (1.30 mL, 18.0 mmol) was 
added to the solution at 0 °C. After stirring at room temperature 
for 15 h, the mixture was concentrated under reduced pressure. 
The residue was purified by recrystallization from MeOH/Et2O 
to give D-tryptophan methyl ester hydrochloride (1.45 g, 95%) 
as a colourless crystalline solid. 
To a solution of D-tryptophan methyl ester hydrochloride 
(1.01 g, 3.95 mmol) in 1,4-dioxane/H2O (1/1, 19 mL) were 
added NaHCO3 (1.16 g, 13.8 mmol) and benzyl chloroformate 
(0.560 mL, 3.95 mmol) at room temperature. After stirring for 
3.5 h, the mixture was extracted twice with EtOAc. The 
combined organic layers were washed with 5% aq. HCl, water 
and brine, dried over Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: hexane/EtOAc = 4/1) to give 11 (1.29 
g, 92%) as a pale yellow viscous oil. [α]D25 –46.2 (c 1.0 in 
CHCl3). νmax (neat)/cm–1 3410, 3360, 3059, 3034, 2952, 2850, 
1741, 1709, 1510, 1456, 1438, 1341, 1265, 1215, 1059, 1027, 
1011, 741, 699. dH (400 MHz, CDCl3) 3.26 (1H, dd, J = 15.1, 
5.5 Hz), 3.28 (1H, dd, J = 15.1, 5.5 Hz), 3.63 (3H, s), 4.70 (1H, 
dt, J = 7.8, 5.5 Hz), 5.05 (1H, d, J = 12.4 Hz), 5.10 (1H, d, J = 
12.4 Hz), 5.39 (1H, br d, J = 7.8 Hz), 6.85 (1H, br d, J = 1.4 
Hz), 7.07 (1H, td, J = 7.3, 1.4 Hz), 7.15 (1H, td, J = 7.3, 1.4 
Hz), 7.20–7.33 (6H, m), 7.50 (1H, br d, J = 7.3 Hz), 8.28 (1H, 
br s). d C (100 MHz, CDCl3) 27.8 (s), 52.3 (s), 54.4 (s), 66.8 (s), 
109.5 (s), 111.2 (s), 118.4 (s), 119.5 (s), 122.0 (s), 122.9 (s), 
127.4 (s), 128.0 (s), 128.1 (s), 128.4 (s), 136.0 (s), 136.1 (s), 
155.8 (s), 172.4 (s). MS (EI) m/z 353 ([M+H]+), 352 ([M]+). 
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Scheme 5 Synthesis of 10b-fluorinated analogue 4 and 5a,10b-epimer 26. 
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HRMS (EI) calcd for C20H20N2O4 ([M]+): 352.1423, found 
352.1424. 
(2R,3aRS,8aSR)-3a-Fluoro-3,3a,8,8a-tetrahydropyrrolo[2,3-
b]indole-1,2(2H)-dicarboxylic acid 1-benzyl 2-methyl ester (13a 
and 13b). 
To a solution of 11 (1.06 g, 3.00 mmol) in anhydrous THF (300 
mL) was added 7 (1.30 g, 4.50 mmol) at room temperature. 
After stirring at 60 °C for 8.5 h, the mixture was concentrated 
under reduced pressure. The residue was dissolved in EtOAc, 
washed with water and brine, dried over Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified 
by silica gel column chromatography (eluent: hexane/EtOAc = 
4/1) to give an inseparable mixture of 13a and 13b (13a:13b = 
ca. 1:1, 926 mg, 83%) as a pale yellow viscous oil. Each of 13a 
and 13b was observed as a mixture of two rotamers (13a: ca. 
7:10 ratio, 13b: ca. 7:10 ratio) in 1H and 19F NMR. dH (400 
MHz, CDCl3) 2.61–3.04 (4H, m), 3.17 (30/17H, s), 3.28 
(21/17H, s), 3.60 (30/17H, s), 3.79 (21/17H, s), 4.47 (10/17H, 
dd, J = 8.7, 4.6 Hz), 4.53 (7/17H, dd, J = 8.7, 4.6 Hz), 4.66–
4.87 (2H, m), 5.03–5.30 (5H, m), 5.53 (7/17H, d, J = 17.4 Hz), 
5.56 (10/17H, d, J = 17.4 Hz), 5.73 (7/17H, dd, J = 22.0, 3.2 
Hz), 5.76 (10/17H, dd, J = 22.0, 3.2 Hz), 6.59–6.69 (2H, m), 
6.75–6.85 (2H, m), 7.19–7.41 (14H, m). dF (376 MHz, CDCl3) 
–139.2 (7/17F, m), –139.7 (7/17F, br t, J = 16.2 Hz), –139.8 
(10/17F, m), –141.4 (10/17F, br t, J = 16.6 Hz). MS (EI) m/z 
371 ([M+H]+), 370 ([M]+), 350 ([M–HF]+). 
(2R,3aR,8aS)-8-Acetyl-3a-fluoro-3,3a,8,8a-
tetrahydropyrrolo[2,3-b]indole-1,2(2H)-dicarboxylic acid 1-
benzyl 2-methyl ester (14a) and (2R,3aS,8aR)-8-acetyl-3a-fluoro-
3,3a,8,8a-tetrahydropyrrolo[2,3-b]indole-1,2(2H)-dicarboxylic 
acid 1-benzyl 2-methyl ester (14b). 
To a solution of a mixture of 13a and 13b (13a:13b = ca. 1:1, 
198 mg, 0.535 mmol) in acetic anhydride (2.10 mL) was added 
pyridine (0.130 mL, 1.60 mmol) at room temperature. After 
stirring at 60 °C for 48 h, the mixture was diluted with CHCl3. 
The mixture was then washed sat. aq. NaHCO3, water, 5% aq. 
citric acid, water and brine. The resulting organic layer was 
dried over Na2SO4, filtered and concentrated under reduced 
pressure. The residue was purified by silica gel column 
chromatography (eluent: hexane/EtOAc = 3/1) to give a 
mixture of 14a and 14b (14a:14b = ca. 1:1, 180 mg, 82%) as a 
pale yellow amorphous solid. Each of 14a and 14b gave the 
following data after partial separation by silica gel column 
chromatography (eluent: hexane/EtOAc = 3/1) and 
recrystallisation from hexane/CH2Cl2. 
14a: colourless crystalline solid. Mp 153–154 °C (from 
hexane/CH2Cl2). [α]D25 –80.8 (c 1.0 in CHCl3). νmax 
(KBr)/cm–1 3033, 3002, 2956, 1761, 1736, 1707, 1675, 1604, 
1478, 1467, 1422, 1389, 1361, 1335, 1311, 1285, 1248, 1217, 
1197, 1172, 1139, 1094, 1061, 1022, 924, 768, 756, 727, 707. 
dH (400 MHz, CDCl3, a mixture of two rotamers in ca. 1:5 
ratio) 2.19 (1/2H, br s), 2.65 (5/2H, br s), 2.90–3.02 (2H, m), 
3.09 (3H, br s), 4.75 (1H, br d, J = 6.0 Hz), 5.16 (2H, s), 6.13 
(1H, br d, J = 11.5 Hz), 7.16 (1H, t, J = 7.3 Hz), 7.26–7.38 (6H, 
m), 7.42–7.46 (1H, m), 8.06 (1H, br s). dC (100 MHz, CDCl3, 
major rotamer) 23.5 (s), 37.1 (br s), 52.2 (s), 59.3 (d, J = 5.8 
Hz), 67.9 (s), 80.6 (d, J = 32.6 Hz), 102.2 (d, J = 207.0 Hz), 
119.3 (s), 124.3 (s), 124.6 (s), 126.6 (d, J = 21.1 Hz), 127.9 (s), 
128.4 (s), 128.6 (s), 132.2 (d, J = 3.8 Hz), 135.4 (s), 144.8 (s), 
154.0 (s), 170.0 (s), 170.9 (br s). dF (376 MHz, CDCl3, a 
mixture of two rotamers in ca. 1:5 ratio) –142.7 (1/6F, br s), –
143.0 (5/6F, br s). MS (EI) m/z 413 ([M+H]+), 412 ([M]+). 
HRMS (EI) calcd for C22H21FN2O5 ([M]+): 412.1434, found 
412.1430. 
14b: colourless needles. Mp 110–112 °C (from 
hexane/CH2Cl2). [α]D 25 +148.5 (c 1.0 in CHCl3). νmax 
(KBr)/cm–1 3063, 3037, 2980, 2952, 1743, 1708, 1676, 1480, 
1418, 1385, 1357, 1343, 1291, 1215, 1179, 1044, 974, 917, 785, 
761, 742, 699. dH (400 MHz, CDCl3, a mixture of two rotamers 
in ca. 1:2.5 ratio) 2.08 (6/7H, br s), 2.63–2.72 (22/7H, m), 3.01 
(1H, dd, J = 12.4, 7.3 Hz), 3.43 (15/7H, br s), 3.78 (6/7H, br s), 
4.07 (1H, dd, J = 10.1, 7.3 Hz), 4.88 (4/7H, br s), 5.15 (20/21H, 
s), 5.17 (10/21H, s), 6.09 (1H, br s), 7.22 (1H, t, J = 7.3 Hz), 
7.33 (5H, br s), 7.44–7.50 (2H, m), 7.95 (2/7H, br s), 8.11 
(5/7H, br s). dC (100 MHz, CDCl3, major rotamer) 23.7 (s), 
35.2 (d, J = 26.8 Hz), 52.4 (s), 58.7 (s), 67.8 (s), 80.2 (d, J = 
36.4 Hz), 100.8 (d, J = 205.1 Hz), 119.7 (s), 123.9 (s), 124.9 (s), 
126.9 (d, J = 20.1 Hz), 128.4 (s), 128.5 (s), 128.7 (s), 132.3 (d, 
J = 2.9 Hz), 135.0 (s), 143.8 (s), 153.0 (s), 170.8 (s), 171.4 (s). 
dF (376 MHz, CDCl3, a mixture of two rotamers in ca. 1:2.5 
ratio) –142.0 (2/7F, br s), –142.4 (5/7F, br s). MS (EI) m/z 413 
([M+H]+), 412 ([M]+). HRMS (EI) calcd for C22H21FN2O5 
([M]+): 412.1434, found 412.1428. 
(2R,3aR,8aR)-8-Acetyl-3a-fluoro-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid methyl ester 
(15a) and (2R,3aS,8aS)-8-acetyl-3a-fluoro-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid methyl ester 
(15b). 
To a solution of a mixture of 14a and 14b (14a:14b = ca. 1:1, 
113 mg, 0.274 mmol) in MeOH (0.6 mL) was added 10% 
palladium on carbon (23 mg) at room temperature. After 
stirring under 3–4 atm of hydrogen for 2 h, the mixture was 
filtered through a small pad of celite and concentrated under 
reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: hexane/EtOAc = 2/3) to give 15a (34 
mg, 45%) and 15b (33 mg, 43%). 
15a: pale yellow viscous oil. [α]D 25 +19.0 (c 0.93 in CHCl3). 
νmax (neat)/cm–1 3344, 3001, 2952, 2853, 1740, 1666, 1606, 
1483, 1467, 1436, 1396, 1356, 1317, 1294, 1218, 1144, 1092, 
1053, 1021, 944, 914, 850, 836, 760, 736. dH (400 MHz, 
CDCl3, a mixture of two rotamers in ca. 1:2 ratio) 2.37 (2H, br 
s), 2.47 (1H, br s), 2.56–3.01 (3H, m), 3.42 (2H, br s), 3.47 (1H, 
br s), 4.12–4.18 (1H, m), 5.49 (2/3H, br d, J = 18.8 Hz), 5.68 
(1/3H, br d, J = 22.0 Hz), 7.15 (1H, t, J = 7.8 Hz), 7.40 (1H, t, J 
= 7.8 Hz), 7.49 (1H, br d, J = 7.8 Hz), 8.22 (1H, br d, J = 7.8 
Hz). dC (100 MHz, CDCl3, major rotamer) 23.7 (s), 39.9 (d, J = 
31.6 Hz), 52.3 (s), 59.3 (s), 83.1 (d, J = 30.7 Hz), 105.2 (d, J = 
197.4 Hz), 117.7 (s), 123.8 (s), 124.5 (s), 125.9 (s), 131.6 (d, J 
= 39.3 Hz), 143.4 (br s), 168.7 (s), 172.3 (s). dF (376 MHz, 
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CDCl3, a mixture of two rotamers in ca. 1:2 ratio) –136.9 (2/3F, 
td, J = 18.4, 9.5 Hz), –137.8 (1/3F, td, J = 20.4, 13.5 Hz). MS 
(EI) m/z 279 ([M+H]+), 278 ([M]+), 258 ([M–HF]+), 219 ([M–
CO2Me]+). HRMS (EI) calcd for C14H15FN2O3 ([M]+): 
278.1067, found 278.1067. 
15b: colourless viscous oil. [α]D 25 +49.3 (c 0.67 in CHCl3). 
νmax (neat)/cm–1 3330, 2955, 2927, 2853, 1740, 1668, 1605, 
1483, 1468, 1393, 1357, 1312, 1287, 1252, 1217, 1199, 1180, 
1136, 1092, 1064, 1032, 1013, 957, 916, 820, 799, 762. dH 
(400 MHz, CDCl3, a mixture of two rotamers in ca. 1:4 ratio) 
2.35 (12/5H, s), 2.48 (3/5H, s), 2.64–2.81 (2H, m), 3.27 (4/5H, 
br s), 3.62 (1/5H, br s), 3.78 (3H, s), 3.71–3.88 (1H, m), 5.66 
(4/5H, br d, J = 18.8 Hz), 5.85 (1/5H, br d, J = 19.7 Hz), 7.17 
(1H, dd, J = 7.8, 7.3 Hz), 7.40–7.53 (2H, m), 8.27 (1H, br d, J = 
7.8 Hz). dC (100 MHz, CDCl3, major rotamer) 24.0 (s), 42.5 (d, 
J = 30.7 Hz), 52.6 (s), 59.0 (s), 83.3 (d, J = 29.7 Hz), 107.0 (d, 
J = 197.9 Hz), 117.4 (s), 124.3 (s), 124.4 (s), 126.9 (d, J = 23.0 
Hz), 131.9 (s), 143.6 (d, J = 2.9 Hz), 169.4 (s), 172.8 (s). dF 
(376 MHz, CDCl3, a mixture of two rotamers in ca. 1:4 ratio) –
138.6 – –138.7 (4/5F, br m), –139.5 (1/5F, br s). MS (EI) m/z 
279 ([M+H]+), 278 ([M]+), 258 ([M–HF]+), 219 ([M–CO2Me]+). 
HRMS (EI) calcd for C14H15FN2O3 ([M]+): 278.1067, found 
278.1070. 
N-(Benzyloxycarbonyl)-L-leucyl-D-tryptophan methyl ester (18). 
To a solution of D-tryptophan methyl ester (17) (1.40 g, 6.40 
mmol), obtained by neutralisation of its hydrochloride, and N-
carbobenzyloxy-L-leucine (2.04 g, 7.70 mmol) in anhydrous 
DMF (32 mL) were added HOBt (1.04 g, 7.70 mmol), 
EDC·HCl (1.48 g, 7.70 mmol) and NMM (0.94 mL, 8.30 
mmol) at 0 °C. After stirring for 18 h, the mixture was diluted 
with sat. aq. NaHCO3 and extracted three times with EtOAc. 
The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated under reduced pressure. 
The residue was purified by silica gel column chromatography 
(eluent: hexane/EtOAc = 3/2) to give 18 (2.47 g, 83%) as a 
colourless crystalline solid. Mp 133–134 °C (from 
hexane/CHCl3). [α]D25 –51.9 (c 0.75 in CHCl3). νmax 
(KBr)/cm–1  3410, 3392, 3320, 2957, 2930, 2871, 1755, 1739, 
1689, 1656, 1533, 1457, 1439, 1351, 1341, 1321, 1267, 1230, 
1217, 1112, 1050, 1022, 743, 698. dH (400 MHz, CDCl3) 0.84 
(3H, d, J = 6.0 Hz), 0.85 (3H, d, J = 6.0 Hz), 1.36–1.45 (1H, m), 
1.50–1.60 (2H, m), 3.26 (1H, dd, J = 15.1, 5.5 Hz), 3.30 (1H, 
dd, J = 15.1, 5.5 Hz), 3.64 (3H, s), 4.16–4.21 (1H, m), 4.87–
4.91 (1H, m), 5.04 (1H, d, J = 12.4 Hz), 5.10 (1H, br d, J = 7.3 
Hz), 5.11 (1H, d, J = 12.4 Hz), 6.60 (1H, br d, J = 7.3 Hz), 6.90 
(1H, br s), 7.09 (1H, ddd, J = 7.8, 6.9, 0.9 Hz), 7.16 (1H, ddd, J 
= 8.2, 6.9, 0.9 Hz), 7.30 (2H, dt, J = 8.2, 0.9 Hz), 7.31–7.36 
(4H, br m), 7.50 (1H, br d, J = 7.8 Hz), 7.95 (1H, br s). dC (100 
MHz, CDCl3) 21.6 (s), 22.9 (s), 24.6 (s), 27.4 (s), 41.3 (s), 52.4 
(s), 52.6 (s), 53.6 (s), 67.0 (s), 109.5 (s), 111.2 (s), 118.4 (s), 
119.6 (s), 122.1 (s), 123.0 (s), 127.4 (s), 128.1 (s), 128.2 (s), 
128.5 (s), 136.0 (s), 136.2 (s), 156.1 (s), 172.0 (s), 172.2 (s). 
MS (EI) m/z 466 ([M+H]+), 465 ([M]+). HRMS (EI) calcd for 
C26H31N3O5 ([M]+): 465.2264, found 465.2263. 
(2R,3aRS,8aSR)-1-[(2S)-2-Benzyloxycarbonylamino-4-
methylpentanoyl]-3a-fluoro-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole-2-carboxylic acid methyl ester (20a and 20b). 
To a solution of 18 (931 mg, 2.00 mmol) in anhydrous THF 
(200 mL) was added 7 (868 mg, 3.00 mmol) at room 
temperature. After stirring at 60 °C for 7.5 h, the mixture was 
concentrated under reduced pressure. The residue was dissolved 
in EtOAc, washed with water and brine, dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue 
was purified by silica gel column chromatography (eluent: 
hexane/EtOAc = 3/1) to give an inseparable mixture of 20a and 
20b (20a:20b = ca. 1:1, 814 mg, 84%) as a colourless viscous 
oil. Each of 20a and 20b was observed as a mixture of two 
rotamers (20a: ca. 1:1 ratio, 20b: ca. 1:2 ratio) in 1H and 19F 
NMR.  dH (400 MHz, CDCl3) 0.77 (3/2H, d, J = 6.4Hz), 0.87 
(5H, d, J = 6.4Hz), 0.93 (2H, d, J = 6.4Hz), 0.97 (1H, d, J = 
6.4Hz), 1.00 (5/2H, d, J = 6.4Hz), 1.43–1.80 (6H, m), 2.55–
3.11 (4H, m), 3.14 (3/2H, s), 3.28 (3/2H, s), 3.73 (1H, s), 3.83 
(2H, s), 4.24 (1/2H, td, J = 9.6, 3.2 Hz), 4.31 (2/3H, td, J = 9.6, 
3.7 Hz), 4.58 (1/2H, td, J = 9.6, 5.0 Hz), 4.64 (1/3H, dd, J = 8.7, 
4.6 Hz), 4.88 (1/3H, td, J = 10.1, 5.5 Hz), 4.90–5.40 (29/3H, m), 
5.62 (1H, dd, J = 17.4, 7.3 Hz), 5.83 (2/3H, dd, J = 25.2, 4.1 
Hz), 5.90 (1/3H, dd, J = 22.0, 5.5 Hz), 6.64 (2/3H, d, J = 7.8 
Hz), 6.65 (1/2H, d, J = 7.8 Hz), 6.78 (1/2H, t, J = 7.8 Hz), 
6.821 (1/3H, d, J = 7.8 Hz), 6.824 (2/3H, t, J = 7.8 Hz), 6.96 
(1/3H, t, J = 7.8 Hz), 7.20–7.37 (15H, m). dF (376 MHz, 
CDCl3) –131.6 (1/3F, q, J = 20.2 Hz), –138.1 – –138.2 (1/2F, 
m), –141.8 (1/2F, br dd, J = 17.5, 11.3 Hz), –145.0 (2/3F, ddd, 
J = 32.8, 25.6, 17.5 Hz). MS (EI) m/z 483 ([M]+), 463 ([M–
HF]+). 
(2R,3aR,8aR)-8-Acetyl-1-[(2S)-2-benzyloxycarbonylamino-4-
methylpentanoyl]-3a-fluoro-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole-2-carboxylic acid methyl ester (8) and (2R,3aS,8aS)-8-
acetyl-1-[(2S)-2-benzyloxycarbonylamino-4-methylpentanoyl]-
3a-fluoro-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-
carboxylic acid methyl ester (21). 
Method A: To a solution of a mixture of 20a and 20b (20a:20b 
= ca. 1:1, 169 mg, 0.350 mmol) in acetic anhydride (1.40 mL) 
was added pyridine (0.085 mL, 1.05 mmol) at room 
temperature. After stirring at 60 °C for 42 h, the mixture was 
diluted with CHCl3. The mixture was then washed sat. aq. 
NaHCO3, water, 5% aq. citric acid, water and brine. The 
resulting organic layer was dried over Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified 
by silica gel column chromatography (eluent: hexane/EtOAc = 
3/1) to give a mixture of 8 and 21 (8:21 = ca. 2:1, 120 mg, 
65%) and 20b (containing small amounts of unidentified side 
products, 37 mg, <22%). 
Method B: Acetylation of a mixture of 20a and 20b (20a:20b = 
ca. 1:1, 193 mg, 0.400 mmol) with acetic anhydride (1.60 mL) 
and pyridine (0.100 mL, 1.24 mmol) at 60 °C for 3 h gave a 
mixture of 8 and 21 (8:21 = ca. 17:1, 95 mg, 45%) and 20b (91 
mg, 47%). Compound 20b (86 mg, 0.178 mmol) was acetylated 
again with acetic anhydride (1.00 mL) and pyridine (0.0600 mL, 
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0.742 mmol) at 60 °C for 50 h to generate 21 (49 mg, 52%) and 
20b (35 mg, 41%). 
8: colourless needles. Mp 166–167 °C (from hexane/CH2Cl2). 
[α]D 25 –113.1 (c 0.5 in CHCl3). νmax (KBr)/cm–1 3374, 2959, 
2871, 1717, 1687, 1673, 1509, 1477, 1468, 1456, 1419, 1386, 
1339, 1321, 1285, 1255, 1226, 1212, 1171, 1142, 1128, 1096, 
1058, 1038, 1021, 960, 919, 842, 805, 782, 762, 700. dH (400 
MHz, CDCl3) 0.76 (3H, d, J = 6.4 Hz), 0.88 (3H, d, J = 6.4 Hz), 
1.43–1.51 (1H, m), 1.58–1.68 (2H, m), 2.61 (3H, s), 2.98 (1H, 
td, J = 12.8, 8.7 Hz), 3.16 (1H, d, J = 12.8 Hz), 3.21 (3H, s), 
4.16–4.22 (1H, m), 5.07 (1H, d, J = 12.4 Hz), 5.12 (1H, d, J = 
12.4 Hz), 5.28 (1H, br d, J = 8.7 Hz), 5.48 (1H, br d, J = 8.7 
Hz), 6.31 (1H, br d, J = 12.4 Hz), 7.17 (1H, dd, J = 7.8, 7.3 Hz), 
7.31–7.45 (7H, m), 8.06 (1H, br d, J = 8.2 Hz). dC (100 MHz, 
CDCl3) 21.1 (s), 23.3 (s), 23.5 (s), 24.4 (s), 37.7 (d, J = 29.7 
Hz), 40.9 (s), 50.3 (s), 52.5 (s), 59.9 (d, J = 5.8 Hz), 67.3 (s), 
79.8 (d, J = 32.6 Hz), 102.0 (d, J = 204.2 Hz), 119.4 (s), 124.5 
(d, J = 6.7 Hz), 124.6 (s), 126.3 (d, J = 22.0 Hz), 128.0 (s), 
128.3 (s), 128.6 (s), 132.2 (d, J = 2.9 Hz), 135.8 (s), 145.0 (d, J 
= 3.8 Hz), 156.5 (s), 169.7 (s), 171.0 (s), 174.3 (s). dF (376 
MHz, CDCl3, a mixture of two rotamers in ca. 1:16 ratio) –
142.4 (1/17F, br s), –143.9 (16/17F, br t, J = 12.2 Hz). MS (EI) 
m/z 526 ([M+H]+), 525 ([M]+). HRMS (EI) calcd for 
C28H32FN3O6 ([M]+): 525.2275, found 525.2271. 
21: colourless crystalline solid. Mp 157–158 °C (from 
hexane/CH2Cl2). [α]D 25 +28.9 (c 0.25 in CHCl3). νmax 
(KBr)/cm–1 3242, 3033, 2994, 2953, 2868, 1749, 1703, 1685, 
1672, 1607, 1539, 1479, 1469, 1415, 1389, 1317, 1294, 1260, 
1219, 1179, 1051, 995, 941, 781, 758, 741, 700. dH (400 MHz, 
CDCl3, a mixture of two rotamers in ca. 1:3 ratio) 0.71–0.97 
(3H, br m), 0.89 (3H, d, J = 6.4 Hz), 1.21–1.44 (1H, br m), 
1.49–1.80 (2H, br m), 2.19–2.79 (4H, br m), 2.80–3.29 (1H, br 
m), 3.60–4.10 (1H, br m), 3.70 (3/4H, br s), 3.83 (9/4H, br s), 
4.58–5.33 (4H, br m), 6.08 (3/4H, br s), 6.83 (1/4H, br s), 7.15–
7.59 (35/4H, br m), 7.97 (1/4H, br s). dF (376 MHz, CDCl3, a 
mixture of two rotamers in ca. 1:3 ratio) –144.2 (3/4F, br s), –
144.4 (1/4F, br s). MS (EI) m/z 526 ([M+H]+), 525 ([M]+). 
HRMS (EI) calcd for C28H32FN3O6 ([M]+): 525.2275, found 
525.2281. 
20b: colourless crystalline solid. Mp 49–51 °C (dec.). [α]D25 
+150.4 (c 0.4 in CHCl3). νmax (KBr)/cm–1 3396, 3331, 2956, 
2871, 1749, 1714, 1653, 1618, 1523, 1486, 1472, 1437, 1322, 
1301, 1257, 1219, 1187, 1094, 1058, 922, 753, 698. dH (400 
MHz, CDCl3, a mixture of two rotamers in ca. 1:2 ratio) 0.87 
(2H, d, J = 6.4 Hz), 0.93 (2H, d, J = 6.4 Hz), 0.97 (1H, d, J = 
6.4 Hz), 1.00 (1H, d, J = 6.4 Hz), 1.53–1.60 (1H, m), 1.65–1.78 
(2H, m), 2.54–2.70 (1H, m), 2.79 (1/3H, ddd, J = 19.2, 14.2, 4.6 
Hz), 2.97 (2/3H, dd, J = 17.4, 14.2 Hz), 3.72 (1H, s), 3.83 (2H, 
s), 4.32 (2/3H, td, J = 9.6, 3.7 Hz), 4.64 (1/3H, dd, J = 8.7, 4.6 
Hz), 4.88 (1/3H, ddd, J = 10.1, 8.7, 5.5 Hz), 5.02 (2/3H, d, J = 
12.4 Hz), 5.08 (2/3H, d, J = 12.4 Hz), 5.12 (1/3H, d, J = 11.9 
Hz), 5.16 (1/3H, d, J = 11.9 Hz), 5.25–5.41 (8/3H, m), 5.82 
(2/3H, dd, J = 25.7, 4.1 Hz), 5.90 (1/3H, dd, J = 22.4, 5.5 Hz), 
6.63 (2/3H, d, J = 7.8 Hz), 6.820 (2/3H, t, J = 7.8 Hz), 6.823 
(1/3H, d, J = 7.3 Hz), 6.96 (1/3H, t, J = 7.3 Hz), 7.21 (2/3H, t, J 
= 7.8 Hz), 7.26–7.36 (19/3H, m). dC (100 MHz, CDCl3, major 
rotamer) 21.4 (s), 23.4 (s), 24.2 (s), 40.5 (s), 41.4 (d, J = 31.6 
Hz), 50.3 (s), 53.0 (s), 60.1 (s), 67.1 (s), 84.1 (d, J = 27.8 Hz), 
106.7 (d, J = 195.1 Hz), 110.5 (s), 119.4 (s), 123.4 (s), 126.5 (d, 
J = 24.0 Hz), 127.9 (s), 128.2 (s), 128.5 (s), 131.2 (s), 136.0 (s), 
148.3 (d, J = 4.8 Hz), 156.2 (s), 171.7 (s), 173.5 (s). dF (376 
MHz, CDCl3, a mixture of two rotamers in ca. 1:2 ratio) –131.6 
(1/3F, q, J = 20.7 Hz), –145.0 (2/3F, ddd, J = 32.8, 25.2, 17.5 
Hz). MS (EI) m/z 484 ([M+H]+), 483 ([M]+), 463 ([M–HF]+). 
HRMS (EI) calcd for C26H30FN3O5 ([M]+): 483.2169, found 
483.2157. 
(3S,5aR,10bR,11aR)-6-Acetyl-10b-fluoro-6,10b,11,11a-
tetrahydro-3-(2-methylpropyl)-2H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione (3). 
To a solution of 8 (109 mg, 0.207 mmol) in MeOH (0.4 mL) 
was added 10% palladium on carbon (22 mg) at room 
temperature. After stirring under 3–4 atm of hydrogen for 4 h, 
the mixture was filtered through a small pad of celite and 
concentrated under reduced pressure. The residue was purified 
by silica gel column chromatography (eluent: hexane/EtOAc = 
2/3) to give 3 (37 mg, 50%) as a colourless crystalline solid. 
Mp 182–183 °C (from hexane/CH2Cl2). [α]D 25 +27.3 (c 0.50 in 
CHCl3). νmax (KBr)/cm–1 3286, 2960, 2931, 2874, 1686, 1480, 
1468, 1418, 1385, 1330, 1292, 1185, 1146, 1096, 1061, 1040, 
937, 771, 759. dH (400 MHz, CDCl3) 0.91 (3H, d, J = 6.4 Hz), 
0.97 (3H, d, J = 6.4 Hz), 1.63 (2H, dd, J = 7.8, 6.4 Hz), 1.71 
(1H, septet, J = 6.4 Hz), 2.55 (3H, s), 2.92 (1H, ddd, J = 18.8, 
14.2, 10.5 Hz), 3.37 (1H, dt, J = 14.2, 4.6 Hz), 3.77 (1H, td, J = 
7.8, 4.6 Hz), 4.52 (1H, dd, J = 10.5, 4.6 Hz), 5.96 (1H, d, J = 
12.4 Hz), 6.68 (1H, br d, J = 4.6 Hz), 7.17 (1H, dd, J = 7.8, 7.3 
Hz), 7.39 (1H, tt, J = 7.8, 1.8 Hz), 7.47 (1H, dt, J = 7.3, 1.8 Hz), 
8.00 (1H, br d, J = 7.8 Hz). dC (100 MHz, CDCl3) 21.1 (s), 
22.9 (s), 24.3 (s), 24.5 (s), 32.3 (d, J = 30.7 Hz), 41.3 (s), 55.8 
(d, J = 4.8 Hz), 56.0 (s), 81.3 (d, J = 33.6 Hz), 100.9 (d, J = 
201.3 Hz), 118.8 (s), 124.9 (s), 125.0 (d, J = 2.9 Hz), 127.6 (d, 
J = 22.0 Hz), 132.1 (d, J = 2.9 Hz), 142.8 (d, J = 3.8 Hz), 167.4 
(s), 167.8 (s), 170.4 (s). dF (376 MHz, CDCl3) –138.4 (1F, br t, 
J = 15.3 Hz). MS (EI) m/z 359 ([M]+). HRMS (EI) calcd for 
C19H22FN3O3 ([M]+): 359.1645, found 359.1637. 
(3S,5aS,10bS,11aR)-6-Acetyl-10b-fluoro-6,10b,11,11a-
tetrahydro-3-(2-methylpropyl)-2H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione (22). 
To a solution of 21 (49 mg, 0.0930 mmol) in MeOH (0.4 mL) 
was added 10% palladium on carbon (10 mg) at room 
temperature. After stirring under 3–4 atm of hydrogen for 2 h, 
the mixture was filtered through a small pad of celite and 
concentrated under reduced pressure. The residue was purified 
by silica gel column chromatography (eluent: hexane/EtOAc = 
2/3) to give 22 (26 mg, 78%) as colourless needles. Mp 214–
216 °C (from hexane/CH2Cl2). [α]D25 +212.6 (c 0.20 in 
CHCl3). νmax (KBr)/cm–1 3233, 3161, 2968, 2932, 2871, 1685, 
1669, 1645, 1483, 1466, 1437, 1392, 1330, 1294, 1200, 1146, 
1090, 1060, 1037, 820, 793, 757. dH (400 MHz, CDCl3) 0.92 
(3H, d, J = 6.4 Hz), 0.94 (3H, d, J = 6.4 Hz), 1.50–1.75 (3H, m), 
2.62 (3H, s), 2.75 (1H, dt, J = 13.7, 12.4 Hz), 3.07 (1H, dd, J = 
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12.4, 5.5 Hz), 3.92–4.02 (2H, m), 6.37 (1H, d, J = 13.3 Hz), 
7.04 (1H, br d, J = 2.8 Hz), 7.26 (1H, dd, J = 7.8, 7.3 Hz), 
7.46–7.52 (2H, m), 8.17 (1H, br d, J = 7.8 Hz). dC (100 MHz, 
CDCl3) 21.3 (s), 22.9 (s), 23.8 (s), 24.2 (s), 40.0 (d, J = 29.7 
Hz), 43.9 (s), 55.7 (s), 58.2 (d, J = 5.8 Hz), 79.8 (d, J = 32.6 
Hz), 102.0 (d, J = 204.2 Hz), 119.0 (s), 124.2 (s), 125.3 (d, J = 
2.9 Hz), 126.0 (d, J = 22.0 Hz), 132.4 (d, J = 2.9 Hz), 144.5 (d, 
J = 3.8 Hz), 166.45 (s), 166.49 (s), 170.9 (s). dF (376 MHz, 
CDCl3) –144.6 (1F, br t, J = 13.5 Hz). MS (EI) m/z 359 ([M]+). 
HRMS (EI) calcd for C19H22FN3O3 ([M]+): 359.1645, found 
359.1652. 
(2S,3aRS,8aSR)-1-[(2S)-2-Benzyloxycarbonylamino-4-
methylpentanoyl]-3a-fluoro-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid methyl 
ester (24a and 24b). 
Fluorocyclisation of N-Cbz-L-Leu-L-Trp-OMe (23)17 (349 mg, 
0.75 mmol) with 7 (325 mg, 1.13 mmol) in anhydrous THF (75 
mL) at 60 °C for 7 h in a similar manner to that of 18 gave an 
inseparable mixture of 24a and 24b (24a:24b = ca. 1:1, 279 mg, 
77%) as a colourless viscous oil. Each of 24a and 24b was 
observed as a mixture of two rotamers (24a: ca. 1:2 ratio, 24b: 
ca. 1:4 ratio) in 1H and 19F NMR. dH (500 MHz, CDCl3) 0.88 
(3/5H, d, J = 6.3 Hz), 0.941 (2H, d, J = 6.3 Hz), 0.944 (3/5H, d, 
J = 6.3 Hz), 0.97 (2H, d, J = 6.3 Hz), 1.00 (12/5H, d, J = 6.9 
Hz), 1.01 (12/5H, d, J = 6.9 Hz), 1.02 (1H, d, J = 6.3 Hz), 1.06 
(1H, d, J = 6.3 Hz), 1.35–1.86 (6H, m), 2.63–3.13 (4H, m), 3.17 
(2H, s), 3.31 (1H, s), 3.747 (3/5H, s), 3.754 (12/5H, s), 4.38–
4.43 (13/15H, m), 4.47 (4/5H, t, J = 8.0 Hz), 4.55 (4/5H, td, J = 
9.2, 5.7 Hz), 4.64 (2/3H, br d, J = 8.0 Hz), 4.65 (1/5H, br d, J = 
9.2 Hz), 4.70 (1/3H, td, J = 9.7, 4.6 Hz), 4.77 (1/3H, br d, J = 
4.0 Hz), 4.996 (1/3H, br d, J = 9.2 Hz), 5.001 (1/3H, br d, J = 
9.2 Hz), 5.02 (2/3H, d, J = 12.6 Hz), 5.06 (2/3H, d, J = 12.6 Hz), 
5.10 (1/3H, d, J = 12.0 Hz), 5.11 (2/5H, s), 5.12 (4/5H, d, J = 
12.0 Hz), 5.13 (1/3H, d, J = 12.0 Hz), 5.15 (4/5H, d, J = 12.0 
Hz), 5.26 (1/5H, br d, J = 9.2 Hz), 5.31 (2/3H, br s), 5.33 (4/5H, 
br d, J = 9.2 Hz), 5.41 (1/5H, br d, J = 9.2 Hz), 5.43 (2/3H, br d, 
J = 9.2 Hz), 5.59 (2/3H, d, J = 17.8 Hz), 5.81 (4/5H, dd, J = 
18.9, 2.3 Hz), 5.87 (1/5H, dd, J = 25.8, 4.0 Hz), 5.97 (1/3H, dd, 
J = 17.8, 4.0 Hz), 6.49 (4/5H, br d, J = 2.3 Hz), 6.61 (4/5H, d, J 
= 8.0 Hz), 6.63 (2/3H, d, J = 8.0 Hz), 6.66 (1/5H, d, J = 8.0 Hz), 
6.77 (2/3H, t, J = 8.0 Hz), 6.81 (1/3H, d, J = 8.0 Hz), 6.83 
(4/5H, t, J = 8.0 Hz), 6.84 (1/5H, t, J = 8.0 Hz), 6.93 (1/3H, t, J 
= 8.0 Hz), 7.18–7.39 (14H, m). dF (470 MHz, CDCl3) –133.3 – 
–133.4 (1/3F, m), –140.8 – –141.0 (5/3F, m). MS (EI) m/z 483 
([M]+), 463 ([M–HF]+). 
(2S,3aS,8aS)-8-Acetyl-1-[(2S)-2-benzyloxycarbonylamino-4-
methylpentanoyl]-3a-fluoro-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole-2-carboxylic acid methyl ester (25a) and (2S,3aR,8aR)-
8-acetyl-1-[(2S)-2-benzyloxycarbonylamino-4-methylpentanoyl]-
3a-fluoro-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-
carboxylic acid methyl ester (25b). 
Acetylation of a mixture of 24a and 24b (24a:24b = ca. 1:1, 
224 mg, 0.463 mmol) with acetic anhydride (1.85 mL) and 
pyridine (0.110 mL, 1.39 mmol) at 60 °C for 4 h in a similar 
manner to that of 20a and 20b gave a mixture of 25a and 25b 
(25a:25b = ca. 30:1, 120 mg, 49%) and 24b (97 mg, 43%). 
Compound 24b (76 mg, 0.157 mmol) was acetylated again with 
acetic anhydride (0.63 mL) and pyridine (0.0380 mL, 0.472 
mmol) at 60 °C for 50 h to generate 25b (43 mg, 52%) and 24b 
(17 mg, 22%). The data of pure 25a was obtained after 
recrystallization of the mixture of 25a and 25b from hexane and 
dichloromethane. 
25a: colourless needles. Mp 131–132 °C (from 
hexane/CH2Cl2). [α]D23 +27.5 (c 0.5 in CHCl3). νmax 
(KBr)/cm–1 3414, 2952, 1726, 1677, 1670, 1513, 1480, 1468, 
1419, 1385, 1343, 1321, 1287, 1224, 1172, 1142, 1097, 1062, 
1040, 1028, 775, 751, 698. dH (500 MHz, CDCl3, a mixture of 
two rotamers in ca. 1:2 ratio) 0.93–0.96 (6H, br m), 1.34–1.38 
(2/3H, br m), 1.52–1.80 (7/3H, br m), 2.44 (1H, br s), 2.63 (2H, 
br s), 2.75–3.20 (2H, br m), 3.06 (2H, br s), 3.18 (1H, br s), 
4.38 (2/3H, br t, J = 8.6 Hz), 4.61 (2/3H, br d, J = 8.6 Hz), 
4.99–5.37 (4H, br m), 6.19 (2/3H, br d, J = 12.0 Hz), 7.03 
(1/3H, br d, J = 8.0 Hz), 7.14–7.47 (8H, br m), 8.03 (2/3H, br d, 
J = 6.3 Hz). d C (126 MHz, CDCl3) 21.6 (s), 23.4 (s), 23.7 (s), 
24.4 (s), 37.6 (d, J = 31.2 Hz), 43.0 (s), 50.4 (s), 52.8 (s), 59.3 
(d, J = 4.8 Hz), 66.9 (s), 80.4 (d, J = 32.4 Hz), 101.5 (d, J = 
203.9 Hz), 119.3 (s), 124.6 (d, J = 12.0 Hz), 125.6 (s), 128.0 (s 
x 2), 128.1 (s), 128.4 (s), 132.3 (s), 136.1 (s), 145.1 (s), 155.5 
(s), 169.0 (s), 171.2 (s), 172.8 (s). dF (470 MHz, CDCl3, a 
mixture of two rotamers in ca. 1:2 ratio) –143.7 (2/3F, br s), –
143.8 (1/3F, br s). MS (EI) m/z 526 ([M+H]+), 525 ([M]+). 
HRMS (EI) calcd for C28H32FN3O6 ([M]+): 525.2275, found 
525.2275. 
25b: colourless crystalline solid. Mp 56–59 °C (from 
hexane/CHCl3). [α]D23 –67.2 (c 0.75 in CHCl3). νmax 
(KBr)/cm–1 3385, 2956, 2871, 1752, 1721, 1683, 1608, 1520, 
1481, 1468, 1416, 1370, 1326, 1288, 1281, 1257, 1246, 1214, 
1174, 1043, 778, 760, 740, 699. dH (500 MHz, CDCl3, a 
mixture of two rotamers in ca. 1:3 ratio) 0.60 (3/4H, d, J = 6.3 
Hz), 0.71 (3/4H, d, J = 6.3 Hz), 0.83–0.90 (1/4H, m), 1.02 
(9/4H, d, J = 6.9 Hz), 1.08 (9/4H, d, J = 6.9 Hz), 1.19–1.35 
(1/2H, m), 1.45–1.51 (3/4H, m), 1.65–1.70 (3/4H, m), 1.83 
(3/4H, septet, J = 6.9 Hz), 2.43 (9/4H, s), 2.62 (3/4H, td, J = 
12.6, 11.5 Hz), 2.63 (3/4H, s), 2.77 (1/4H, td, J = 13.2, 9.7 Hz), 
2.95 (3/4H, dd, J = 12.6, 6.9 Hz), 3.19 (1/4H, dd, J = 13.2, 8.6 
Hz), 3.72 (9/4H, s), 3.77 (3/4H, s), 4.01 (3/4H, dd, J = 11.5, 6.9 
Hz), 4.08 (1/4H, td, J = 8.6, 5.2 Hz), 4.17 (1/4H, br t, J = 8.6 
Hz), 5.00–5.07 (7/2H, m), 5.35 (1/4H, br d, J = 9.2 Hz), 6.13 
(1/4H, d, J = 9.2 Hz), 6.64 (3/4H, d, J = 8.0 Hz), 7.09 (3/4H, d, 
J = 8.0 Hz), 7.22–7.49 (8H, m), 8.02 (1/4H, br d, J = 8.0 Hz). 
dC (126 MHz, CDCl3, major rotamer) 22.1 (s), 23.0 (s), 23.4 
(s), 24.9 (s), 33.7 (d, J = 26.4 Hz), 42.4 (s), 50.2 (s), 52.4 (s), 
59.0 (d, J = 3.6 Hz), 66.6 (s), 77.7 (d, J = 33.6 Hz), 100.2 (d, J 
= 205.1 Hz), 119.5 (s), 124.7 (s), 125.7 (s), 127.9 (s), 128.0 (s), 
128.4 (s), 129.1 (d, J = 21.6 Hz), 132.1 (d, J = 2.4 Hz), 136.7 
(s), 143.4 (d, J = 3.6 Hz), 155.4 (s), 170.5 (s), 171.8 (s), 174.9 
(s). dF (470 MHz, CDCl3, a mixture of two rotamers in ca. 1:3 
ratio) –144.3 (3/4F, br t, J = 10.3 Hz), –144.8 (1/4F, br t, J = 
11.4 Hz). MS (EI) m/z 526 ([M+H]+), 525 ([M]+). HRMS (EI) 
calcd for C28H32FN3O6 ([M]+): 525.2275, found 525.2261. 
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24b: colourless crystalline solid. Mp 45–47 °C (dec.) (from 
hexane/CH2Cl2). [α]D25 –178.5 (c 0.5 in CHCl3). νmax 
(KBr)/cm–1 3317, 2956, 2871, 1752, 1717, 1698, 1654, 1618, 
1541, 1523, 1474, 1437, 1320, 1259, 1216, 1190, 1177, 1121, 
1095, 1057, 749, 698. dH (500 MHz, CDCl3, a mixture of two 
rotamers in ca. 1:4 ratio) 0.86 (3/5H, d, J = 6.3 Hz), 0.93 (3/5H, 
d, J = 6.3 Hz), 0.99 (12/5H, d, J = 6.9 Hz), 1.00 (12/5H, d, J = 
6.9 Hz), 1.35 (1/5H, ddd, J = 14.3, 9.7, 4.0 Hz), 1.52 (1/5H, ddd, 
J = 14.3, 9.7, 4.6 Hz), 1.61–1.71 (8/5H, m), 1.77–1.85 (1H, m), 
2.60–2.79 (9/5H, m), 2.98–3.05 (1/5H, m), 3.73 (12/5H, s), 
3.74 (3/5H, s), 4.41 (1/5H, td, J = 9.7, 4.0 Hz), 4.45 (4/5H, t, J 
= 8.0 Hz), 4.56 (4/5H, td, J = 9.2, 5.7 Hz), 4.63 (1/5H, br d, J = 
8.0 Hz), 5.08 (2/5H, s), 5.11 (4/5H, d, J = 12.6 Hz), 5.13 (4/5H, 
d, J = 12.6 Hz), 5.37 (1/5H, br d, J = 4.0 Hz), 5.55 (1/5H, d, J = 
9.2 Hz), 5.63 (4/5H, d, J = 9.7 Hz), 5.81 (4/5H, dd, J = 18.9, 
2.3 Hz), 5.85 (1/5H, dd, J = 25.5, 4.0 Hz), 6.54 (4/5H, br d, J = 
2.3 Hz), 6.59 (4/5H, d, J = 8.0 Hz), 6.64 (1/5H, d, J = 8.0 Hz), 
6.82 (1H, br t, J = 8.0 Hz), 7.19–7.22 (1H, m), 7.28–7.34 (6H, 
m). d C (126 MHz, CDCl3, major rotamer) 22.1 (s), 23.1 (s), 
24.3 (s), 38.6 (d, J = 31.2 Hz), 42.0 (s), 50.9 (s), 52.5 (s), 59.5 
(s), 67.4 (s), 80.9 (d, J = 30.0 Hz), 107.5 (d, J = 199.1 Hz), 
110.6 (s), 119.5 (d, J = 2.4 Hz), 123.81 (s), 123.85 (d, J = 22.8 
Hz), 128.0 (s), 128.3 (s), 128.6 (s), 131.9 (d, J = 2.4 Hz), 135.9 
(s), 149.4 (d, J = 4.8 Hz), 156.8 (s), 170.6 (s), 172.8 (s). dF (470 
MHz, CDCl3, a mixture of two rotamers in ca. 1:4 ratio) –140.8 
– –140.9 (4/5F, m), –140.8 – –141.0 (1/5F, m). MS (EI) m/z 
484 ([M+H]+), 483 ([M]+). HRMS (EI) calcd for C26H30FN3O5 
([M]+): 483.2169, found 483.2151. 
(3S,5aR,10bR,11aS)-6-Acetyl-10b-fluoro-6,10b,11,11a-
tetrahydro-3-(2-methylpropyl)-2H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione (4). 
Deprotection and subsequent DKP formation of 25b (42 mg, 
0.080 mmol) using 10% palladium on carbon (8 mg) in MeOH 
(1.0 mL) at room temperature for 1.5 h in a similar manner to 
those of 8 gave 4 (25 mg, 87%) as a colourless crystalline solid. 
Mp 93–96 °C (from hexane/CHCl3). [α]D22 –244.6 (c 0.40 in 
CHCl3). νmax (KBr)/cm–1 3246, 2959, 2930, 2871, 1685, 1480, 
1467, 1408, 1384, 1351, 1332, 1295, 1284, 1179, 1158, 1143, 
1104, 1092, 1061, 1045, 925, 767, 755. dH (500 MHz, CDCl3) 
0.92 (3H, d, J = 6.3 Hz), 1.00 (3H, d, J = 6.3 Hz), 1.58 (1H, 
ddd, J = 14.4, 9.8, 5.2 Hz), 1.72–1.80 (1H, m), 2.01 (1H, ddd, J 
= 14.4, 9.8, 3.5 Hz), 2.65 (3H, s), 2.79 (1H, td, J = 12.6, 12.1 
Hz), 3.07 (1H, dd, J = 12.6, 6.3 Hz), 3.97–4.01 (2H, m), 6.24 
(1H, d, J = 12.1 Hz), 6.58 (1H, s), 7.24 (1H, t, J = 7.5 Hz), 
7.46–7.52 (2H, m), 8.13 (1H, br d, J = 8.0 Hz). dC (126 MHz, 
CDCl3) 21.1 (s), 23.3 (s), 23.8 (s), 24.3 (s), 37.8 (d, J = 30.0 
Hz), 39.0 (s), 53.1 (s), 58.8 (d, J = 6.0 Hz), 79.8 (d, J = 32.4 
Hz), 101.7 (d, J = 205.1 Hz), 119.3 (s), 124.1 (s), 125.2 (d, J = 
2.4 Hz), 126.2 (d, J = 22.8 Hz), 132.4 (d, J = 3.6 Hz), 144.5 (d, 
J = 3.6 Hz), 166.5 (s), 167.5 (s), 170.9 (s). d F (470 MHz, 
CDCl3) –144.9 (1F, br t, J = 11.9 Hz). MS (EI) m/z 359 ([M]+). 
HRMS (EI) calcd for C19H22FN3O3 ([M]+): 359.1645, found 
359.1653. 
(3S,5aS,10bS,11aS)-6-Acetyl-10b-fluoro-6,10b,11,11a-
tetrahydro-3-(2-methylpropyl)-2H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione 
(26). 
Deprotection and subsequent DKP formation of 25a (53 mg, 
0.100 mmol) using 10% palladium on carbon (11 mg) in MeOH 
(1.0 mL) at room temperature for 5 h in a similar manner to 
those of 8 gave 26 (31 mg, 86%) as a colourless crystalline 
solid. Mp 105–106 °C (from hexane/CH2Cl2). [α]D25 –15.5 (c 
0.40 in CHCl3). νmax (KBr)/cm–1 3227, 3120, 2959, 2937, 2871, 
1689, 1680, 1673, 1480, 1468, 1406, 1385, 1334, 1293, 1184, 
1042, 938, 769, 755. dH (500 MHz, CDCl3) 0.89 (3H, d, J = 
6.3 Hz), 0.90 (3H, d, J = 6.3 Hz), 1.42 (1H, ddd, J = 14.3, 9.7, 
5.2 Hz), 1.56–1.65 (1H, m), 1.91 (1H, ddd, J = 14.3, 9.7, 4.0 
Hz), 2.58 (3H, s), 2.91 (1H, ddd, J = 17.8, 14.3, 10.9 Hz), 3.51 
(1H, ddd, J = 14.3, 3.4, 1.7 Hz), 3.90 (1H, dd, J = 9.7, 4.0 Hz), 
4.50 (1H, dd, J = 10.9, 3.4 Hz), 5.62 (1H, s), 5.98 (1H, d, J = 
11.5 Hz), 7.19 (1H, t, J = 7.5 Hz), 7.42 (1H, dddd, J = 8.6, 7.5, 
2.3, 1.2 Hz), 7.52 (1H, br d, J = 7.5 Hz), 7.99 (1H, br d, J = 8.6 
Hz). dC (126 MHz, CDCl3) 21.1 (s), 23.0 (s), 24.2 (s), 24.5 (s), 
30.9 (d, J = 30.0 Hz), 37.7 (s), 53.5 (s), 57.5 (d, J = 6.0 Hz), 
80.8 (d, J = 33.6 Hz), 101.2 (d, J = 201.5 Hz), 118.9 (s), 125.0 
(d, J = 2.4 Hz), 125.1 (s), 127.3 (d, J = 21.6 Hz), 132.2 (d, J = 
3.6 Hz), 142.9 (d, J = 4.8 Hz), 167.9 (s), 168.1 (s), 170.2 (s). dF 
(470 MHz, CDCl3) –138.5 (1F, br t, J = 14.1 Hz). MS (EI) m/z 
359 ([M]+), 339 ([M–HF]+). HRMS (EI) calcd for 
C19H22FN3O3 ([M]+): 359.1645, found 359.1638. 
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